Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has become the first ... mechanisms of action there could be scope for combination use. There are now two vaccines to protect against ...

Jardiance is also authorised to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. According to the FDA, heart disease impacts more than ...